U.S. markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.88-1.12 (-2.73%)
At close: 4:00PM EDT

39.92 +0.04 (0.10%)
After hours: 4:26PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close41.00
Open39.83
Bid39.79 x 800
Ask39.92 x 800
Day's Range39.72 - 40.40
52 Week Range29.17 - 46.55
Volume1,949,916
Avg. Volume151,295
Market Cap24.296B
Beta (5Y Monthly)1.08
PE Ratio (TTM)10.80
EPS (TTM)3.69
Earnings DateN/A
Forward Dividend & Yield0.72 (1.75%)
Ex-Dividend DateAug 28, 2020
1y Target Est45.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Here's Why You Should Retain Fresenius Medical Stock Now
    Zacks

    Here's Why You Should Retain Fresenius Medical Stock Now

    Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

  • Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day
    Business Wire

    Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

    Fresenius Medical Care, the world’s leading provider of dialysis products and services, today announced the launch of the organization’s first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific. On 17 September each year, the World Health Organization (WHO), international partners and all countries commemorate World Patient Safety Day: a day that aims to increase global awareness of the need to protect patients in healthcare settings. Fresenius Medical Care Asia Pacific has chosen this important day to highlight the crucial role that ultrapure dialysis fluid (UPDF) plays in reducing morbidity and mortality in hemodialysis (HD) patients,1 and to launch a multi-year initiative providing ongoing healthcare professional education to increase the uptake of high-quality dialysis fluid.

  • Colour blind? How boardroom diversity data eludes advocates
    Reuters

    Colour blind? How boardroom diversity data eludes advocates

    Last month CtW Investment Group urged Fresenius Medical Care AG to add diverse directors to its board. The concern about underrepresentation of minority groups is leading to new data-gathering efforts and legislation.